Longitudinal analysis of 162 liver transplant recipients identified 51 patients who were viremic. Virus load was determined in 47 of these patients using quantitative-competitive polymerase chain reaction. Peak virus load was significantly higher in 20 symptomatic patients than 27 asymptomatic patients (P õ .0001). Elevated virus load, donor seropositivity, and total methylprednisolone dosage were risk factors for human cytomegalovirus (HCMV) disease (odds ratio [OR], 2.22/0.25 log 10 increase in virus load, P Å .001; OR, 4.11, P Å .05; OR, 1.30/1-g increment in methylprednisolone, P Å .01). Methylprednisolone and virus load were independent risk factors in a multivariate analysis (OR, 2.70/1-g increase, P Å .003; OR, 1.61/0.25 log 10 increase, P Å .03, respectively). Virus loads of 10 4.75 -10 5.25 genomes/mL of blood were associated with an increased disease probability; the latter was shifted to lower virus loads with increasing quantities of methylprednisolone. These data illustrate the central role of virus load in HCMV pathogenesis.
Human cytomegalovirus (HCMV) is a recognized cause of that rapid detection of HCMV DNA-emia via polymerase chain reaction (PCR) of plasma, sera, and whole blood can provide both morbidity and mortality following solid organ transplantation [1, 2] . HCMV is the most common cause of infection prognostic information for liver transplant recipients [13 -20] , suggesting that preemptive therapy could be used in these pafollowing liver transplantation, with an incidence of 20% -60%, and Ç50% of infected patients will proceed to develop tients, as has been described for HCMV infection following bone marrow transplantation [21] . HCMV disease. Risk factors for disease include receipt of large doses of immunosuppressive therapy, transplantation of an orStagno et al. [22] in 1975 first reported the relationship between the quantity of HCMV and the development of disgan from an HCMV-seropositive donor into an HCMV-seronegative recipient, and the appearance of viremia [2 -5] . Cliniease. They demonstrated that HCMV virus titer was directly related to disease in congenitally infected infants [22] . Recent cal manifestations appear typically within the first 3 months after transplant and range from persistent fever and mononuclecross-sectional and longitudinal studies in human immunodeficiency virus -positive patients and renal transplant and bone osis-like syndrome to more severe invasive organ disease, such as HCMV hepatitis, gastrointestinal disease, and pneumonitis marrow transplant patients have shown that quantity of virus (HCMV) is usually higher in patients with symptomatic infec- [6] .
With the development of effective antiviral agents against tion [23 -27] . In liver transplant recipients, one study using a semiquantitative PCR assay to follow 40 liver transplant pa-HCMV, the emphasis has focused more recently on earlier intervention strategies to reduce incidence of disease [7 -12] . A tients showed a significant correlation between high levels of HCMV DNA in blood and development of disease [28] . Howrandomized, controlled prophylactic trial of ganciclovir versus high-dose acyclovir showed ganciclovir to be more effective ever, no detailed longitudinal studies of liver transplant recipients have been done using fully quantitative PCR methods to at preventing HCMV disease [7, 10] . Indeed, one randomized trial has shown short-course preemptive ganciclovir therapy to determine the relative contributions of virus load in the context of other risk factors for disease; we now report such a study. be more effective than high-dose acyclovir at preventing HCMV disease [9] . The results of many studies have confirmed (4 mg/kg/24 hr intravenously [iv] ) from days 1 to 3 after transplant, test (differences in virus load). Significant relationships were then quantified using logistic regression analysis, and the results were adjusted according to plasma levels and renal function of the patient. Moderate to severe rejection, diagnosed histologically, was used to generate an equation to determine the probability of being symptomatic at any given virus load in the presence or absence treated with methylprednisolone (1 g daily iv for 3 days), which was repeated if a subsequent rejection episode occurred. Steroidof methylprednisolone in an independent manor irrespective of the timing of HCMV infection. For these analyses, odds ratios quoted resistant rejection was treated with either OKT3 for 5 days or antithymocyte globulin for 10 days, and cyclosporin was replaced refer to each 0.25 log 10 increase in virus load and each 1-g increase in methylprednisolone. with FK506 (0.1 mg/kg daily) in the case of chronic rejection.
Ampicillin (1 g four times daily iv), netilmicin (3.5 mg/kg twice daily iv), and metronidazole (500 mg three times daily iv) were given for bacterial prophylaxis and amphotericin (5 mL four times ). ; P õ .0001, figure 2A In the D//R/ group, the 9 patients who had HCMV virus total dose of methylprednisolone were independent risk factors for HCMV disease, with ORs of 2.70 (per 0.25-log 10 increase) loads above the median (10 4.94 genomes/mL of blood) were significantly more at risk of disease than the 10 patients with and 1.61 (per 1-g increase), respectively. On the basis of the logistic regression analysis, we conlevels below the median virus load (P Å .02, Fisher's exact test). Virus load was also significantly higher in the symptomstructed disease probability curves for increasing virus loads in the univariate setting ( figure 3A ) and similar curves to invesatic patients (median, 10 5.57 genomes/mL; range, 10 4.94 -10 7.53 ; n Å 7) versus the asymptomatic patients (median, 10 4.58 getigate the influence of total methylprednisolone on the virus load -disease curve in the multivariate setting ( figure 3B ). The nomes/mL; range, 10 3.64 -10
; n Å 12, P õ .01, Mann-Whitney U test). The symptomatic patients in the D//R/ group graph illustrates a rapid increase in the probability of disease had a median virus load comparable to that of symptomatic patients within the primary infection group. ropositivity identified in this study are consistent with previous data from our group and others [3 -5, 33] . By using multivariate
logistic regression analysis, the association of donor-recipient serostatus as a risk factor was explained by elevated virus load. / 9d3b$$de05 10-30-97 12:13:33 jinfa UC: J Infect Therefore, we suggest that virus load is the mechanism through and augmented methylprednisolone administration. The use of virus load increases above critical levels to identify patients at which this risk factor is associated with disease (i.e., patients with primary infection have HCMV disease because of a high risk of future disease is an attractive option, but further studies are required to ascertain whether such an approach would be virus load).
In contrast, both methylprednisolone and elevated virus load applicable in the clinical setting.
In conclusion, the detailed analysis of patients by measurewere identified in the multivariate analysis as independent risk factors for disease. This observation implies that receipt of ment of virus load in surveillance samples may offer the possibility of designing algorithms that will predict whether a patient large quantities of methylprednisolone for rejection episodes predisposes the individual to HCMV disease at lower virus will go on to develop HCMV disease. Such monitoring, together with the knowledge of other risk factors, such as donor loads. In contrast, high virus loads are necessary to produce pathologic consequences in patients who experience relatively seropositivity and methylprednisolone usage, not only may identify patients at risk of disease but also will help prevent few rejection episodes and therefore require lower levels of augmented methylprednisolone.
patients receiving unnecessary treatment with antiviral therapy. The disease probability -virus load curves computed from the logistic regression analysis support the interpretation that analysis with more patients will elucidate whether the temporal were more likely to be experiencing primary infection than 
